N-acetylated cysteine conjugates (premercapturic acids) of bromobenzene 3,4-oxide were found to act as precursors of 3- and 4-bromophenol in the rat and guinea pig. The formation of phenols through this pathway is species dependent. The guinea pig shows a higher conversion than the rat and this difference could be due to the degree of acetylate/deacetylate process of cysteine conjugates. This route to phenols may be the major mode of phenol formation for many aromatic compounds whose metabolism involve the reaction of oxides with glutathione. This pathway may be responsible for bromobenzene toxicity in high dosage. The toxicity could be due to the formation of hydrogen sulfide, or to the formation of thiocatechols and/or thioquinones.
The specific aims of this proposed studies are: 1. To study the generality of this sulfur-conjugate pathway to the formation of phenols. Several types of aromatic compounds will be tested. The premercapturic acids will be biosynthesized and purified. Each will be administered to the guinia pig and rat, and the formation of phenols by this pathway will be examined. 2. To define the sequence of reactions and emphasis will be placed on the identification of the direct intermediate for the formation of 3- and 4-bromophenol. The 4-S- and 3-S-cysteine and mercaptopyruvate conjugates and the methylthiohydroxydihydro metabolites of bromobenzene will be synthesized. Each will be tested both in vivo an in vitro for the formation of 3- and 4-bromophenol and the mechanism of sulfur elimination will be studied. 3. To determine the role of acetylation in phenol formation. Synthetic 4-S- and 3-S-cysteine conjugates of bromobenzene will be administered to three differences strain of mice (A/J, C57BL/6J, Swiss Webster). The affect of fast and slow acetylation to the formation of 3- and 4-bromophenol will be examined. 4. The toxicity of the reactive intermediates which could be formed in this sulfur-conjugate pathway to phenols will be studied. Synthetic 4-S- and 3-S-cysteine and mercaptopyruvate conjugate of bromobenzene will be administered to guinea pig, rat and mice, and the liver and kidney toxicity will be examined.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29ES004857-05
Application #
3465253
Study Section
Toxicology Subcommittee 2 (TOX)
Project Start
1988-08-01
Project End
1994-07-31
Budget Start
1992-08-01
Budget End
1994-07-31
Support Year
5
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Type
Schools of Medicine
DUNS #
041367053
City
Galveston
State
TX
Country
United States
Zip Code
77555
Lertratanangkoon, K; Orkiszewski, R S; Scimeca, J M (1996) Methyl-donor deficiency due to chemically induced glutathione depletion. Cancer Res 56:995-1005
Lertratanangkoon, K (1993) O- and S-methylated bromothiocatechols. Toxicol Appl Pharmacol 122:200-7
Lertratanangkoon, K; Denney, D (1993) Formation of phenol and thiocatechol metabolites from bromobenzene premercapturic acids through pyridoxal phosphate-dependent C-S lyase activity. Biochem Pharmacol 45:2513-25
Lertratanangkoon, K; Horning, E C; Horning, M G (1993) Pathways of formation of 2-, 3- and 4-bromophenol from bromobenzene. Proposed mechanism for C-S lyase reactions of cysteine conjugates. Res Commun Chem Pathol Pharmacol 80:259-82
Lertratanangkoon, K; Scimeca, J M (1993) Prevention of bromobenzene toxicity by N-acetylmethionine: correlation between toxicity and the impairment in O- and S-methylation of bromothiocatechols. Toxicol Appl Pharmacol 122:191-9